“I was fortunate to have crossed-paths with Dr. Kohli at Otsuka oncology division. In my several scientific interactions with Dr. Kohli, I have found him to be an exceptional scientist with wonderful personality, and an amazing team leader who always inspired his team members. During our discourses and group meetings, I have admired him for his profound knowledge in immunotherapy, antibody and genetic engineering targeted towards oncology disease diagnostics and assay development. Dr. Kohli would be an enviable asset to any biotechnology company in his future endeavors. He has a good understanding of underlying molecular chemistry and design, apart from his thorough knowledge in cancer genetics and biologics applications. ”
About
- Senior leader and executive with over 20 years of research, development, and operations…
Activity
-
I am thrilled to announce that I have accepted the AtkinsRéalis position of Senior Vice President and Chief Operating Officer for the United States…
I am thrilled to announce that I have accepted the AtkinsRéalis position of Senior Vice President and Chief Operating Officer for the United States…
Liked by Manu Kohli
-
I am happy to be presenting at the 9th CAR-TCR Summit next week in Boston! If you are attending and want to know more about the Development of Cell…
I am happy to be presenting at the 9th CAR-TCR Summit next week in Boston! If you are attending and want to know more about the Development of Cell…
Liked by Manu Kohli
-
So excited to share this enormous piece of work with you! Led by @YashChhabra while he was here at BMB (now an assistant professor at Fox Chase…
So excited to share this enormous piece of work with you! Led by @YashChhabra while he was here at BMB (now an assistant professor at Fox Chase…
Liked by Manu Kohli
Experience
Education
-
The Johns Hopkins University School of Medicine
Trained with Dr. Bert Vogelstein and Dr. Kenneth Kinzler in cancer genetics and therapeutics
- Studied programmed cell death (apoptosis) in cancer cells, and patented genetic knockout cell lines useful for mechanistic studies as well as for cancer drug discovery.
- Patented adeno-associated virus (AAV) technologies to genetically modify cells to study gene function, which can be applicable to drug discovery (target identification and validation), the advancement of personalized…Trained with Dr. Bert Vogelstein and Dr. Kenneth Kinzler in cancer genetics and therapeutics
- Studied programmed cell death (apoptosis) in cancer cells, and patented genetic knockout cell lines useful for mechanistic studies as well as for cancer drug discovery.
- Patented adeno-associated virus (AAV) technologies to genetically modify cells to study gene function, which can be applicable to drug discovery (target identification and validation), the advancement of personalized medicine, and theranostics.
- Attempted to genetically engineer bacteria (Clostridium novyi) by introducing foreign genes in order to regress tumors in vivo.
- Authored 2 patents on genetic knockout technology and cell lines
- Authored 9 publications on cancer genetics and therapeutics -
Trained with Dr. Timothy Jorgensen, radiation biologist well known for his book "Strange Glow: The Story of Radiation", in cancer biochemistry and genetics, with specific emphasis on DNA repair pathways.
- Authored 3 publications on DNA repair and signal transduction pathways -
Received Biology degree with Honors, summa cum laude
Honors Thesis Research: Mutation spectrum analysis of carcinogenesis by benzo[a]pyrene diol epoxide
- Authored 3 publications on inorganic chemistry research -
High School Valedictorian
Publications
-
Identification of hepatic microvascular adhesion-related genes of human colon cancer cells using random homozygous gene perturbation.
International Journal of Cancer
-
TSG101 exposure on the surface of HIV-1 infected cells: implications for monoclonal antibody therapy for HIV/AIDS.
American Journal of Translational Research
-
Identification of novel host-oriented targets for Human Immunodeficiency Virus Type 1 using Random Homozygous Gene Perturbation.
Virology Journal
-
Function-First Approaches to Improve Target Identification in Cancer.
Future Oncology
-
The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT.
Nature Biotechnology
-
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.
Gastroenterology
-
Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores.
Toxicological Sciences
-
Glutathione S-transferase π1 promotes tumorigenicity in HCT116 human colon cancer cells.
Cancer Research
-
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells.
Proceedings of the National Academy of Sciences
-
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells.
Cancer Research
-
Tumour suppression: disruption of HAUSP gene stabilizes p53.
Nature
-
An efficient method for generating human somatic cell gene knockouts.
Discovery Medicine
-
Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses.
Nucleic Acids Research
-
Lack of dependence on p53 for DNA double strand break repair of episomal vectors in human lymphoblasts.
Biochemical and Biophysical Research Communications
-
Determination of human DNA polymerase utilization for the repair of a model ionizing radiation-induced DNA strand break lesion in a defined vector substrate.
Nucleic Acids Research
-
The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses.
Biochemical and Biophysical Research Communications
-
The source of the cloud produced upon adding dry ice to water.
Journal of Chemical Education
-
Rhenium Dihydrogen Complexes and Long H-H Interactions: X-ray-Determined Single-Crystal Structures of ReCl(.eta.2-H2)(Ph2PCH2CH2PPh2)2.cntdot.THF and [ReO2(Ph2PCH:CHPPh2)2][ReO4].
Inorganic Chemistry
-
Another bogus isomer: sic transit "green tetrachlorotetrakis(methyldiphenylphosphine)dimolybdenum". The x-ray crystal structure determination of trichlorobis(methyldiphenylphosphine oxide)oxomolybdenum.benzene.
Inorganic Chemistry
Recommendations received
4 people have recommended Manu
Join now to viewMore activity by Manu
-
FHWA Administrator Shailen Bhatt spoke to thousands of cyclists who turned their ride into a powerful reminder of our collective mission: safer roads…
FHWA Administrator Shailen Bhatt spoke to thousands of cyclists who turned their ride into a powerful reminder of our collective mission: safer roads…
Liked by Manu Kohli
-
For the first time ever, a 13-year-old boy has been cured of a deadly brain cancer The boy’s tumor disappeared after participating in a new clinical…
For the first time ever, a 13-year-old boy has been cured of a deadly brain cancer The boy’s tumor disappeared after participating in a new clinical…
Liked by Manu Kohli
-
Excited to see the latest advancements in CAR-T technology highlighted in Science Signaling. The innovative work on CAPs and CAR-TKs could be a…
Excited to see the latest advancements in CAR-T technology highlighted in Science Signaling. The innovative work on CAPs and CAR-TKs could be a…
Liked by Manu Kohli
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Manu Kohli
-
Manu Kohli
Chartering Manager at Westlink
-
Manu Kohli
EV enthusiast and Business Developer
-
Manu Kohli
Associate Professor at Chitkara University
-
Manu Kohli
AREA HEAD
28 others named Manu Kohli are on LinkedIn
See others named Manu Kohli